Influence of the Protein Kinase C Activator Phorbol Myristate Acetate on the Intracellular Activity of Antibiotics against Hemin- and Menadione-Auxotrophic Small-Colony Variant Mutants of Staphylococcus aureus and Their Wild-Type Parental Strain in Human THP-1 Cells

Pharmacodynamic Evaluation of the Activity of Antibiotics against Hemin- and Menadione-Dependent Small-Colony Variants of Staphylococcus aureus in Models of Extracellular (Broth) and Intracellular (THP-1 Monocytes) Infections

(2012) L. G. Garcia et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Macrophage Killing of Bacterial and Fungal Pathogens Is Not Inhibited by Intense Intracellular Accumulation of the Lipoglycopeptide Antibiotic Oritavancin

(2012) Beverlie Baquir et al.   CLINICAL INFECTIOUS DISEASES

In Vivo Activity of Oritavancin in Animal Infection Models and Rationale for a New Dosing Regimen in Humans

(2012) P. G. Ambrose et al.   CLINICAL INFECTIOUS DISEASES

Integrin-mediated uptake of fibronectin-binding bacteria

(2011) Christine Hoffmann et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus

(2011) Francis F. Arhin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes

(2011) Evgeny A. Idelevich et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial Actions of Reactive Oxygen Species

(2011) F. C. Fang   mBio

Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro

(2010) F. Sachse et al.   ALLERGY

Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila

(2010) S. Lemaire et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing

(2010) A. Belley et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint

(2010) S. Lemaire et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

How antibiotics kill bacteria: from targets to networks

(2010) Michael A. Kohanski et al.   NATURE REVIEWS MICROBIOLOGY

The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages

(2010) Marc Daigneault et al.   PLoS One

Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Pharmacodynamic Evaluation and Comparison with Isogenic Normal-Phenotype and Revertant Strains

(2009) H. A. Nguyen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of reactive oxygen species in antibiotic action and resistance

(2009) Daniel J Dwyer et al.   CURRENT OPINION IN MICROBIOLOGY

Role ofrsbUand Staphyloxanthin in Phagocytosis and Intracellular Growth ofStaphylococcus aureusin Human Macrophages and Endothelial Cells

(2009) Aurélie C. Olivier et al.   JOURNAL OF INFECTIOUS DISEASES

Retinoid X receptor agonists inhibit phorbol-12-myristate-13-acetate (PMA)-induced differentiation of monocytic THP-1 cells into macrophages

(2009) Lei Zhou et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro

(2008) A. Belley et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages

(2008) Arshad Khan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS